Literature DB >> 2906314

Sequence of mdr3 cDNA encoding a human P-glycoprotein.

A M van der Bliek1, P M Kooiman, C Schneider, P Borst.   

Abstract

We have determined the sequence of the human mdr3 gene using cDNA derived from liver RNA. The mdr3 gene codes for a member of a family of membrane proteins, the P-glycoproteins, overproduced in many multi-drug-resistant (MDR) cell lines. Like its relatives, the protein encoded by mdr3 has a deduced Mr of 140,000, which is presumably increased by glycosylation after synthesis. The sequence consists of two similar halves, each with a series of six hydrophobic segments that may form a membrane channel. The halves also possess nucleotide-binding consensus sequences, which presumably act as ATPases and drive drug transport. The presumed ATPase domains are all but identical to those of the human mdr1 gene product [Chen et al., Cell 47 (1986) 381-389]. We attribute this high level of sequence conservation to the repeated gene conversion that is evident from segments in which mdr1 and mdr3 differ only in a few silent mutations. Divergence between P-glycoprotein family members is greatest at the N terminus and in the 60 amino acid linker connecting the two halves. In the putative trans-membrane domains approx. 80% of the amino acids are conserved between the products of mdr1 and mdr3. Although the function of mdr3 is not yet known, its high homology with mdr1 suggests that it also encodes an efflux pump with broad specificity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906314     DOI: 10.1016/0378-1119(88)90057-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  47 in total

1.  The multiple drug resistance gene, MDR1: expression at the protein and RNA levels.

Authors:  Y Q Li; V Gopal; P Kadam; S Files; H Preisler
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  Cell-specific activity of cis-acting regulatory elements in the promoter of the mouse multidrug resistance gene mdr1.

Authors:  M Raymond; P Gros
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

3.  A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.

Authors:  P Gros; R Dhir; J Croop; F Talbot
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Isolation and characterization of Drosophila multidrug resistance gene homologs.

Authors:  C T Wu; M Budding; M S Griffin; J M Croop
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region.

Authors:  S Bahram; D Arnold; M Bresnahan; J L Strominger; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  P-glycoprotein structure and evolutionary homologies.

Authors:  I Bosch; J M Croop
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 7.  Genetic basis of multidrug resistance of tumor cells.

Authors:  S E Kane; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1990-08       Impact factor: 2.945

8.  Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.

Authors:  S I Hsu; D Cohen; L S Kirschner; L Lothstein; M Hartstein; S B Horwitz
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

9.  Peripheral neuropathy in mice transgenic for a human MDR3 P-glycoprotein mini-gene.

Authors:  J J Smit; F Baas; J E Hoogendijk; G H Jansen; M A van der Valk; A H Schinkel; A J Berns; D Acton; K Nooter; H Burger; S J Smith; P Borst
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

10.  Cloning and regulation of the rat mdr2 gene.

Authors:  P C Brown; S S Thorgeirsson; J A Silverman
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.